189 related articles for article (PubMed ID: 20233883)
1. Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma.
Litvinov IV; Jones DA; Sasseville D; Kupper TS
Clin Cancer Res; 2010 Apr; 16(7):2106-14. PubMed ID: 20233883
[TBL] [Abstract][Full Text] [Related]
2. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).
Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS
Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945
[TBL] [Abstract][Full Text] [Related]
3. Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome.
Shin J; Monti S; Aires DJ; Duvic M; Golub T; Jones DA; Kupper TS
Blood; 2007 Oct; 110(8):3015-27. PubMed ID: 17638852
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
5. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
6. Current status of cutaneous T-cell lymphoma: molecular diagnosis, pathogenesis, therapy and future directions.
Dippel E; Klemke CD; Goerdt S
Onkologie; 2003 Oct; 26(5):477-83. PubMed ID: 14605466
[TBL] [Abstract][Full Text] [Related]
7. Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression.
Borcherding N; Voigt AP; Liu V; Link BK; Zhang W; Jabbari A
Clin Cancer Res; 2019 May; 25(10):2996-3005. PubMed ID: 30718356
[TBL] [Abstract][Full Text] [Related]
8. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
[TBL] [Abstract][Full Text] [Related]
9. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.
Juarez T; Isenhath SN; Polissar NL; Sabath DE; Wood B; Hanke D; Haycox CL; Wood GS; Olerud JE
Arch Dermatol; 2005 Sep; 141(9):1107-13. PubMed ID: 16172307
[TBL] [Abstract][Full Text] [Related]
10. Loss of BCL7A expression correlates with poor disease prognosis in patients with early-stage cutaneous T-cell lymphoma.
Litvinov IV; Zhou Y; Kupper TS; Sasseville D
Leuk Lymphoma; 2013 Mar; 54(3):653-4. PubMed ID: 22856870
[No Abstract] [Full Text] [Related]
11. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors.
Gaydosik AM; Tabib T; Geskin LJ; Bayan CA; Conway JF; Lafyatis R; Fuschiotti P
Clin Cancer Res; 2019 Jul; 25(14):4443-4454. PubMed ID: 31010835
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma.
Shen X; Wang B; Li K; Wang L; Zhao X; Xue F; Shi R; Zheng J
J Invest Dermatol; 2018 Sep; 138(9):2024-2032. PubMed ID: 29559342
[TBL] [Abstract][Full Text] [Related]
14. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E
Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
16. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
17. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.
Zackheim HS; Amin S; Kashani-Sabet M; McMillan A
J Am Acad Dermatol; 1999 Mar; 40(3):418-25. PubMed ID: 10071312
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.
Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593
[TBL] [Abstract][Full Text] [Related]
19. The role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progression.
Litvinov IV; Kupper TS; Sasseville D
Exp Dermatol; 2012 Dec; 21(12):964-6. PubMed ID: 23171462
[TBL] [Abstract][Full Text] [Related]
20. Genomic aberrations and survival in cutaneous T cell lymphomas.
Fischer TC; Gellrich S; Muche JM; Sherev T; Audring H; Neitzel H; Walden P; Sterry W; Tönnies H
J Invest Dermatol; 2004 Mar; 122(3):579-86. PubMed ID: 15086538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]